Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein

Mark R. Palmert; Sandra L. Siedlak; Marcia B. Podlisny; Barry Greenberg; Earl R. Shelton; Hardy Chan; M. Usiak; Dennis J. Selkbe; George Perry; Steven G. Younkin

doi:10.1016/0006-291x(89)91052-8

Related publications

Article1995

Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease

Mark A. Smith, Sandra L. Siedlak, Peggy L. Richey, Paul Mulvihill, Jorge Ghiso, Blas Frangione, Fabrizio Tagliavini, Giorgio Giaccone, Orso Bugiani, Darja Praprotnik, Raj N. Kalaria, George Perry

Article2009

Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β

Rudy J. Castellani, Hyoung‐gon Lee, Sandra L. Siedlak, Akihiko Nunomura, Takaaki Hayashi, Masao Nakamura, Xiongwei Zhu, George Perry, Mark A. Smith

Chapter in a book2019

Transcranial photobiomodulation treats Alzheimer’s disease in amyloid-β protein precursor transgenic mice

Luis De Taboada, Michael R Hamblin

Letter1988

AMYLOID PRECURSOR PROTEIN IN SENILE PLAQUES OF ALZHEIMER DISEASE

George Perry, Sandra Lipphardt, Madhu Kancherla, Pierluigi Gambetti, Linda Maggiora, Thomas J. Lobl, Paul Mulvihill, Magdalena Mijares, Satish Kumar Sharma, James C. Cornette, Barry Greenberg

Article1991

Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.

Patrick Cras, Mitsuru Kawai, David E. Lowery, Patricia A. Gonzalez‐DeWhitt, Barry Greenberg, George Perry